A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal

碩士 === 臺北醫學大學 === 生醫材料暨組織工程研究所 === 106

Bibliographic Details
Main Authors: Ling-Chi Hsiao, 蕭翎綺
Other Authors: Der-Zen Liu
Format: Others
Language:zh-TW
Published: 2018
Online Access:http://ndltd.ncl.edu.tw/handle/2qyq2s
id ndltd-TW-106TMC05723003
record_format oai_dc
spelling ndltd-TW-106TMC057230032019-07-04T05:58:50Z http://ndltd.ncl.edu.tw/handle/2qyq2s A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal 何首烏衍生物合併抗癌藥物應用於乳癌之治療與抗藥性機制探討 Ling-Chi Hsiao 蕭翎綺 碩士 臺北醫學大學 生醫材料暨組織工程研究所 106 Der-Zen Liu 劉得任 2018 學位論文 ; thesis 72 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 臺北醫學大學 === 生醫材料暨組織工程研究所 === 106
author2 Der-Zen Liu
author_facet Der-Zen Liu
Ling-Chi Hsiao
蕭翎綺
author Ling-Chi Hsiao
蕭翎綺
spellingShingle Ling-Chi Hsiao
蕭翎綺
A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal
author_sort Ling-Chi Hsiao
title A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal
title_short A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal
title_full A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal
title_fullStr A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal
title_full_unstemmed A Novel Derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) Combined with Anticancer Drugs for Breast Cancer Treatment and Multidrug Resistance Reversal
title_sort novel derivative of 2, 3, 5, 4‘-tetrahydroxystilbene-2-o-beta-d-glucoside (thsg) combined with anticancer drugs for breast cancer treatment and multidrug resistance reversal
publishDate 2018
url http://ndltd.ncl.edu.tw/handle/2qyq2s
work_keys_str_mv AT lingchihsiao anovelderivativeof2354tetrahydroxystilbene2obetadglucosidethsgcombinedwithanticancerdrugsforbreastcancertreatmentandmultidrugresistancereversal
AT xiāolíngqǐ anovelderivativeof2354tetrahydroxystilbene2obetadglucosidethsgcombinedwithanticancerdrugsforbreastcancertreatmentandmultidrugresistancereversal
AT lingchihsiao héshǒuwūyǎnshēngwùhébìngkàngáiyàowùyīngyòngyúrǔáizhīzhìliáoyǔkàngyàoxìngjīzhìtàntǎo
AT xiāolíngqǐ héshǒuwūyǎnshēngwùhébìngkàngáiyàowùyīngyòngyúrǔáizhīzhìliáoyǔkàngyàoxìngjīzhìtàntǎo
AT lingchihsiao novelderivativeof2354tetrahydroxystilbene2obetadglucosidethsgcombinedwithanticancerdrugsforbreastcancertreatmentandmultidrugresistancereversal
AT xiāolíngqǐ novelderivativeof2354tetrahydroxystilbene2obetadglucosidethsgcombinedwithanticancerdrugsforbreastcancertreatmentandmultidrugresistancereversal
_version_ 1719220551683145728